137 related articles for article (PubMed ID: 3978999)
1. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
[TBL] [Abstract][Full Text] [Related]
2. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
Davison R; Parker M; Atkinson AJ
Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
Sawyer DR; Ludden TM; Crawford MH
Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
[TBL] [Abstract][Full Text] [Related]
4. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.
Pfeifer HJ; Greenblatt DJ; Koch-Weser J
Am Heart J; 1976 Aug; 92(2):168-73. PubMed ID: 941829
[TBL] [Abstract][Full Text] [Related]
5. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
Kettner W; Banditt P; Walther H
Z Gesamte Inn Med; 1984 Jul; 39(14):335-42. PubMed ID: 6485432
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
Routledge PA; Stargel WW; Barchowsky A; Wagner GS; Shand DG
Br J Clin Pharmacol; 1989 Nov; 28(5):593-7. PubMed ID: 2590613
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
Oltmanns D; Lübben C; Pentz R; Siegers CP
Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic principles of lidocaine dosing in relation to disease state.
Waller ES
J Clin Pharmacol; 1981 Apr; 21(4):181-94. PubMed ID: 7240439
[TBL] [Abstract][Full Text] [Related]
9. High-pressure liquid chromatographic determination of lidocaine and its active deethylated metabolites.
Hill J; Roussin A; Lelorier J; Caille G
J Pharm Sci; 1980 Nov; 69(11):1341-3. PubMed ID: 7452468
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
[TBL] [Abstract][Full Text] [Related]
11. Lidocaine kinetics predicted by indocyanine green clearance.
Zito RA; Reid PR
N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
[TBL] [Abstract][Full Text] [Related]
12. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Bax ND; Tucker GT; Woods HF
Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
[TBL] [Abstract][Full Text] [Related]
13. Plasma lidocaine, monoethylglycinexylidide, and glycinexylidide concentrations after epidural administration in geriatric patients.
Fukuda T; Kakiuchi Y; Miyabe M; Okubo N; Yaguchi Y; Kohda Y; Toyooka H
Reg Anesth Pain Med; 2000; 25(3):268-73. PubMed ID: 10834781
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
Fredrick DS; Boersma RB
Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of lignocaine.
Benowitz NL; Meister W
Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of lidocaine and its metabolites after prolonged infusion in healthy horses.
Dickey EJ; McKenzie HC; Brown KA; de Solis CN
Equine Vet J; 2008 Jun; 40(4):348-52. PubMed ID: 18267881
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Nattel S; Gagne G; Pineau M
Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.
LeLorier J; Grenon D; Latour Y; Caillé G; Dumont G; Brosseau A; Solignac A
Ann Intern Med; 1977 Dec; 87(6):700-2. PubMed ID: 931206
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
Drayer DE; Lorenzo B; Werns S; Reidenberg MM
Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
